Search

Current research on the compatibility between plastic liners utilized in Type IV high-pressure hydrogen storage containers and hydrogen remains insufficiently comprehensive. Therefore, further exploration into how the high-pressure hydrogen storage process influences the crystalline phase transition of polymers is essential to improve the applicability and safety of plastic lining materials. This study primarily investigated the preparation of polyamide 1012 (PA1012) and polyamide 11 (PA11) through rotational molding and injection molding, denoted as Roto-PA1012/Roto-PA11 and In-PA1012/In-PA11, respectively. Considering the operational parameters of the 70 MPa Type IV hydrogen storage tank, we conducted hydrogen cycling experiment using the long carbon chain polyamide (LCPA) liner materials and comprehensively analyzed the morphology, crystal structure, grain size, mechanical properties and hydrogen barrier properties of polyamide materials before and after hydrogen cycling. The results showed that after hydrogen cycling, no significant changes were observed in Roto-PA1012/Roto-PA11, while In-PA1012/In-PA11 demonstrated severe foaming. Rotational molding of LCPA maintained stable mechanical and hydrogen barrier properties throughout the hydrogen cycle, which can be attributed to the favorable thermodynamic stability of the α' form achieved during rotational molding, leading to uniform and stable crystal sizes. In conclusion, this study provides a theoretical foundation for future investigations into the molding process and material selection of high-barrier polymer liners, as well as the actual production and utilization of Type IV hydrogen storage tanks. • This research examines the effects of hydrogen circulation on the properties of long carbon chain polyamide (LCPA). • LCPA produced through rotational molding demonstrates better hydrogen compatibility compared to injection molding. • The study explores structural changes in LCPA during hydrogen absorption and desorption. [ABSTRACT FROM AUTHOR]

Within the genus Mycena, species exhibiting brownish basidiomata present considerable challenges in identification due to similar coloration. This study underscores the significance of pileipellis types and cheilocystidia characteristics as critical in delimiting brownish Mycena species. To clarify the principal taxonomic characters and their utility in distinguishing between brownish Mycena species, a morphological taxonomy and phylogenetic analysis were performed. Five new species from China were introduced and characterized through a comprehensive morphological anatomy and phylogenetic substantiation: M. campanulatihemisphaerica sp. nov., M. digitifurcata sp. nov., M. kunyuensis sp. nov., M. limitis sp. nov., and M. oryzifluens sp. nov. Discussions of these taxa are supplemented with morphological illustrations. The phylogenetic relationships were inferred using Bayesian Inference and Maximum Likelihood methods based on sequences from the internal transcribed spacer and the large subunit regions of nuclear ribosomal RNA. With the addition of these five new species, the worldwide count of brownish Mycena increases to 94, and a key to the 29 known species of brownish Mycena from China is presented. [ABSTRACT FROM AUTHOR]

Obesity is an unhealthy condition associated with various diseases characterized by excess fat accumulation. However, in China, the prevalence of obesity is 14.1%, and it remains challenging to achieve weight loss or resolve this issue through clinical interventions. Sanghuangpours vaninii (SPV) is a nutritional fungus with multiple pharmacological activities and serves as an ideal dietary intervention for combating obesity. In this study, a long-term high-fat diet (HFD) was administered to induce obesity in mice. Different doses of SPV and the positive drug simvastatin (SV) were administered to mice to explore their potential anti-obesity effects. SPV regulated weight, serum lipids, and adipocyte size while inhibiting inflammation and hepatic steatosis. Compared with the vehicle-treated HFD-fed mice, the lowest decreases in total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C) were 9.72%, 9.29%, and 12.29%, respectively, and the lowest increase in high-density lipoprotein cholesterol (HDL-C) was 5.88% after treatment with different doses of SPV. With SPV treatment, the analysis of gut microbiota and serum lipids revealed a significant association between lipids and inflammation-related factors, specifically sphingomyelin. Moreover, Western blotting results showed that SPV regulated the toll-like receptor (TLR4)/nuclear factor kappa B (NF-κB) signaling pathway in HFD-diet mice, which is related to inflammation and lipid metabolism. This research presents empirical proof of the impact of SPV therapy on obesity conditions.